Body Weight and Allergic Asthma: A Narrative Review
Abstract
:1. Introduction
2. Are Obese People More Prone to Allergen Sensitization?
3. Are Obese People More Prone to Airway Hyperreactivity?
4. Do Obese People Increase Allergic Inflammation in the Airway?
4.1. Blood Eosinophils
4.2. Sputum and Submucosal Eosinophils
4.3. Type 2 Innate Lymphoid Cells and Alarmins
4.4. FeNO
5. Is Obesity Associated with Dysfunctions of Airway Epithelial Cells?
6. Discussion
7. Conclusions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- León, B.; Ballesteros-Tato, A. Modulating Th2 Cell Immunity for the Treatment of Asthma. Front. Immunol. 2021, 12, 637948. [Google Scholar] [CrossRef] [PubMed]
- Salvi, S.S.; Babu, K.S.; Holgate, S.T. Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am. J. Respir. Crit. Care Med. 2001, 164 Pt 1, 1343–1346. [Google Scholar] [CrossRef]
- Papi, A.; Brightling, C.; Pedersen, S.E.; Reddel, H.K. Asthma. Lancet 2018, 391, 783–800. [Google Scholar] [CrossRef]
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; Global Initiative for Asthma: Fontana, WI, USA, 2020. [Google Scholar]
- Casale, T.B.; Pedersen, S.; del Rio, P.R.; Liu, A.H.; Demoly, P.; Price, D. The Role of Aeroallergen Sensitization Testing in Asthma Management. J. Allergy Clin. Immunol. Pract. 2020, 8, 2526–2532. [Google Scholar] [CrossRef] [PubMed]
- Garg, D.; Que, L.G.; Ingram, J.L. Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity. Front. Pharmacol. 2023, 14, 1315540. [Google Scholar] [CrossRef] [PubMed]
- Zhang, A.; Silverberg, J.I. Association of atopic dermatitis with being overweight and obese: A systematic review and metaanalysis. J. Am. Acad. Dermatol. 2015, 72, 606–616.e4. [Google Scholar] [CrossRef] [PubMed]
- Hersoug, L.G.; Linneberg, A. The link between the epidemics of obesity and allergic diseases: Does obesity induce decreased immune tolerance? Allergy 2007, 62, 1205–1213. [Google Scholar] [CrossRef] [PubMed]
- Nyambuya, T.M.; Dludla, P.V.; Mxinwa, V.; Nkambule, B.B. Obesity-related asthma in children is characterized by T-helper 1 rather than T-helper 2 immune response: A meta-analysis. Ann. Allergy Asthma Immunol. 2020, 125, 425–432.e4. [Google Scholar] [CrossRef] [PubMed]
- A Scott, H.; Ng, S.H.; McLoughlin, R.F.; Valkenborghs, S.R.; Nair, P.; Brown, A.C.; Carroll, O.R.; Horvat, J.C.; Wood, L.G. Effect of obesity on airway and systemic inflammation in adults with asthma: A systematic review and meta-analysis. Thorax 2023, 78, 957–965. [Google Scholar] [CrossRef]
- Lackey, D.E.; Olefsky, J.M. Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 2016, 12, 15–28. [Google Scholar] [CrossRef]
- Azim, A.; Newell, C.; Barber, C.; Harvey, M.; Knight, D.; Freeman, A.; Fong, W.C.G.; Dennison, P.; Haitchi, H.M.; Djukanovic, R.; et al. Clinical evaluation of type 2 disease status in a real-world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts. Clin. Exp. Allergy 2021, 51, 811–820. [Google Scholar] [CrossRef] [PubMed]
- Heaney, L.G.; de Llano, L.P.; Al-Ahmad, M.; Backer, V.; Busby, J.; Canonica, G.W.; Christoff, G.C.; Cosio, B.G.; FitzGerald, J.M.; Heffler, E.; et al. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort. Chest 2021, 160, 814–830. [Google Scholar] [CrossRef]
- Rupani, H.; Kyyaly, M.A.; Azim, A.; Abadalkareen, R.; Freeman, A.; Dennison, P.; Howarth, P.; Djukanovic, R.; Vijayanand, P.; Seumois, G.; et al. Comprehensive Characterization of Difficult-to-Treat Asthma Reveals Near Absence of T2-Low Status. J. Allergy Clin. Immunol. Pract. 2023, 11, 2812–2821.e4. [Google Scholar] [CrossRef] [PubMed]
- Wooldridge, A.L.; McMillan, M.; Kaur, M.; Giles, L.C.; Marshall, H.S.; Gatford, K.L. Relationship between birth weight or fetal growth rate and postnatal allergy: A systematic review. J. Allergy Clin. Immunol. 2019, 144, 1703–1713. [Google Scholar] [CrossRef] [PubMed]
- Vehapoglu, A.; Cakın, Z.E.; Kahraman, F.U.; Nursoy, M.A.; Toprak, A. Is overweight/obesity a risk factor for atopic allergic disease in prepubertal children? A case–control study. J. Pediatr. Endocrinol. Metab. 2021, 34, 727–732. [Google Scholar] [CrossRef] [PubMed]
- Magnusson, J.; Kull, I.; Mai, X.-M.; Wickman, M.; Bergström, A. Early childhood overweight and asthma and allergic sensitization at 8 years of age. Pediatrics 2012, 129, 70–76. [Google Scholar] [CrossRef]
- Lucas, J.A.; Moonie, S.; Olsen-Wilson, K.; Hogan, M.B. Asthma, allergy, and obesity: Examining the relationship among Nevada children. J. Asthma 2017, 54, 594–599. [Google Scholar] [CrossRef] [PubMed]
- Sybilski, A.J.; Raciborski, F.; Lipiec, A.; Tomaszewska, A.; Lusawa, A.; Furmańczyk, K.; Krzych-Fałta, E.; Komorowski, J.; Samoliński, B. Obesity—A risk factor for asthma, but not for atopic dermatitis, allergic rhinitis and sensitization. Public Health Nutr. 2015, 18, 530–536. [Google Scholar] [CrossRef]
- Kölli, F.; Breyer, M.-K.; Hartl, S.; Burghuber, O.; Wouters, E.F.; Sigsgaard, T.; Pohl, W.; Kohlböck, G.; Breyer-Kohansal, R. Aero-Allergen Sensitization in the General Population: Longitudinal Analyses of the LEAD (Lung Heart Social Body) Study. J. Asthma Allergy 2022, 15, 461–473. [Google Scholar] [CrossRef]
- Haarala, A.K.; Sinikumpu, S.-P.; Vaaramo, E.; Jokelainen, J.; Timonen, M.; Auvinen, J.; Pekkanen, J.; Lampi, J.; Huilaja, L. Incidence and remission of aeroallergen sensitization in adults in Northern Finland: 15 years longitudinal study. Sci. Rep. 2021, 11, 4249. [Google Scholar] [CrossRef]
- Johnston, S.L.; Clough, J.B.; Pattemore, P.K.; Smith, S.; Holgate, S.T. Longitudinal changes in skin-prick test reactivity over 2 years in a population of schoolchildren with respiratory symptoms. Clin. Exp. Allergy 1992, 22, 948–957. [Google Scholar] [CrossRef] [PubMed]
- Dottorini, M.L.; Bruni, B.; Peccini, F.; Bottini, P.; Pini, L.; Donato, F.; Casucci, G.; Tantucci, C. Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: A longitudinal study. Clin. Exp. Allergy 2007, 37, 188–196. [Google Scholar] [CrossRef] [PubMed]
- Burgess, J.A.; Matheson, M.C.; Diao, F.; Johns, D.P.; Erbas, B.; Lowe, A.J.; Gurrin, L.C.; Lodge, C.J.; Thomas, P.S.; Morrison, S.; et al. Bronchial hyperresponsiveness and obesity in middle age: Insights from an Australian cohort. Eur. Respir. J. 2017, 50, 1602181. [Google Scholar] [CrossRef] [PubMed]
- Orfanos, S.; Jude, J.; Deeney, B.T.; Cao, G.; Rastogi, D.; van Zee, M.; Pushkarsky, I.; Munoz, H.E.; Damoiseaux, R.; Di Carlo, D.; et al. Obesity increases airway smooth muscle responses to contractile agonists. Am. J. Physiol. Lung Cell. Mol. Physiol. 2018, 315, L673–L681. [Google Scholar] [CrossRef]
- Giesler, A.; Mukherjee, M.; Radford, K.; Janssen, L.; Nair, P. Modulation of human airway smooth muscle biology by human adipocytes. Respir. Res. 2018, 19, 33. [Google Scholar] [CrossRef] [PubMed]
- Xu, S.; Karmacharya, N.; Cao, G.; Guo, C.; Gow, A.; Panettieri, R.A.; Jude, J.A. Obesity elicits a unique metabolomic signature in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2022, 323, L297–L307. [Google Scholar] [CrossRef] [PubMed]
- Habibovic, A.; Hristova, M.; Morris, C.R.; Lin, M.C.J.; Cruz, L.C.; Ather, J.L.; Geiszt, M.; Anathy, V.; Janssen-Heininger, Y.M.; Poynter, M.E.; et al. Diet-induced obesity worsens allergen-induced type 2/type 17 inflammation in airways by enhancing DUOX1 activation. Am. J. Physiol. Lung Cell Mol. Physiol. 2023, 324, L228–L242. [Google Scholar] [CrossRef] [PubMed]
- Athari, S.S. Targeting cell signaling in allergic asthma. Signal Transduct. Target. Ther. 2019, 4, 45. [Google Scholar] [CrossRef]
- Mohamed, S.M.; Refaat, M.M.; Abdel latif, O.M.; Ahmed, E.E. Serum Interleukin 4 Level in Asthma Patient in Relation to Body Mass Index (BMI). QJM A Int. J. Med. 2023, 116, hcad069.494. [Google Scholar] [CrossRef]
- van Huisstede, A.; Rudolphus, A.; Cabezas, M.C.; Biter, L.U.; van de Geijn, G.J.; Taube, C.; Hiemstra, P.S.; Braunstahl, G.J. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax 2015, 70, 659–667. [Google Scholar] [CrossRef]
- Sideleva, O.; Suratt, B.T.; Black, K.E.; Tharp, W.G.; Pratley, R.E.; Forgione, P.; Dienz, O.; Irvin, C.G.; Dixon, A.E. Obesity and asthma: An inflammatory disease of adipose tissue not the airway. Am. J. Respir. Crit. Care Med. 2012, 186, 598–605. [Google Scholar] [CrossRef] [PubMed]
- Pakhale, S.; Baron, J.; Dent, R.; Vandemheen, K.; Aaron, S.D. Effects of weight loss on airway responsiveness in obese adults with asthma: Does weight loss lead to reversibility of asthma? Chest 2015, 147, 1582–1590. [Google Scholar] [CrossRef] [PubMed]
- Dias-Júnior, S.A.; Reis, M.; de Carvalho-Pinto, R.M.; Stelmach, R.; Halpern, A.; Cukier, A. Effects of weight loss on asthma control in obese patients with severe asthma. Eur. Respir. J. 2014, 43, 1368–1377. [Google Scholar] [CrossRef] [PubMed]
- Ricciardolo, F.L.; Sorbello, V.; Ciprandi, G. A pathophysiological approach for FeNO: A biomarker for asthma. Allergol. Immunopathol. 2015, 43, 609–616. [Google Scholar] [CrossRef] [PubMed]
- Mallah, N.; Rodriguez-Segade, S.; Gonzalez-Barcala, F.J.; Takkouche, B. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis. Pediatr. Allergy Immunol. 2021, 32, 465–478. [Google Scholar] [CrossRef] [PubMed]
- Westerhof, G.A.; Korevaar, D.A.; Amelink, M.; de Nijs, S.B.; de Groot, J.C.; Wang, J.; Weersink, E.J.; Brinke, A.T.; Bossuyt, P.M.; Bel, E.H. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur. Respir. J. 2015, 46, 688–696. [Google Scholar] [CrossRef] [PubMed]
- Wagener, A.H.; de Nijs, S.B.; Lutter, R.; Sousa, A.R.; Weersink, E.J.; Bel, E.H.; Sterk, P.J. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax 2015, 70, 115–120. [Google Scholar] [CrossRef] [PubMed]
- Amini, M.; Bashirova, D.; Prins, B.P.; Corpeleijn, E.; LifeLines Cohort Study; Bruinenberg, M.; Franke, L.; van der Harst, P.; Navis, G.; Wolffenbuttel, B.H.R.; et al. Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study. PLoS ONE 2016, 11, e0168480. [Google Scholar] [CrossRef]
- Pongdee, T.; Manemann, S.M.; Decker, P.A.; Larson, N.B.; Moon, S.; Killian, J.M.; Liu, H.; Kita, H.; Bielinski, S.J. Rethinking blood eosinophil counts: Epidemiology, associated chronic diseases, and increased risks of cardiovascular disease. J. Allergy Clin. Immunol. Glob. 2022, 1, 233–240. [Google Scholar] [CrossRef]
- Zhang, H.; Hu, Z.; Wang, S.; Xu, J.; Li, S.; Song, X. Association of general and abdominal obesity with lung function, FeNO, and blood eosinophils in adult asthmatics: Findings from NHANES 2007–2012. Front. Physiol. 2023, 14, 1019123. [Google Scholar] [CrossRef]
- Benson, V.S.; Hartl, S.; Barnes, N.; Galwey, N.; Van Dyke, M.K.; Kwon, N. Blood eosinophil counts in the general population and airways disease: A comprehensive review and meta-analysis. Eur. Respir. J. 2022, 59, 2004590. [Google Scholar] [CrossRef] [PubMed]
- Sunadome, H.; Matsumoto, H.; Izuhara, Y.; Nagasaki, T.; Kanemitsu, Y.; Ishiyama, Y.; Morimoto, C.; Oguma, T.; Ito, I.; Murase, K.; et al. Correlation between eosinophil count, its genetic background and body mass index: The Nagahama Study. Allergol. Int. 2020, 69, 46–52. [Google Scholar] [CrossRef] [PubMed]
- Grotta, M.B.; Squebola-Cola, D.M.; Toro, A.A.; Ribeiro, M.A.G.; Mazon, S.B.; Ribeiro, J.D.; Antunes, E. Obesity increases eosinophil activity in asthmatic children and adolescents. BMC Pulm. Med. 2013, 13, 39. [Google Scholar] [CrossRef] [PubMed]
- Kato, H.; Ueki, S.; Kamada, R.; Kihara, J.; Yamauchi, Y.; Suzuki, T.; Takeda, M.; Itoga, M.; Chihara, M.; Ito, W.; et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int. Arch. Allergy Immunol. 2011, 155, 335–344. [Google Scholar] [CrossRef]
- Yamamoto, R.; Ueki, S.; Moritoki, Y.; Kobayashi, Y.; Oyamada, H.; Konno, Y.; Tamaki, M.; Itoga, M.; Takeda, M.; Ito, W.; et al. Adiponectin attenuates human eosinophil adhesion and chemotaxis: Implications in allergic inflammation. J. Asthma 2013, 50, 828–835. [Google Scholar] [CrossRef] [PubMed]
- Petsky, H.L.; Li, A.; Chang, A.B. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst. Rev. 2017, 8, CD005603. [Google Scholar] [CrossRef]
- Desai, D.; Newby, C.; Symon, F.A.; Haldar, P.; Shah, S.; Gupta, S.; Bafadhel, M.; Singapuri, A.; Siddiqui, S.; Woods, J.; et al. Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am. J. Respir. Crit. Care Med. 2013, 188, 657–663. [Google Scholar] [CrossRef] [PubMed]
- van der Wiel, E.; Ten Hacken, N.H.; van den Berge, M.; Timens, W.; Reddel, H.K.; Postma, D.S. Eosinophilic inflammation in subjects with mild-to-moderate asthma with and without obesity: Disparity between sputum and biopsies. Am. J. Respir. Crit. Care Med. 2014, 189, 1281–1284. [Google Scholar] [CrossRef] [PubMed]
- Lugogo, N.; Green, C.L.; Agada, N.; Zhang, S.; Meghdadpour, S.; Zhou, R.; Yang, S.; Anstrom, K.J.; Israel, E.; Martin, R.; et al. Obesity’s effect on asthma extends to diagnostic criteria. J. Allergy Clin. Immunol. 2018, 141, 1096–1104. [Google Scholar] [CrossRef]
- Kuruvilla, M.; Patrawala, M.; Levy, J.M.; Shih, J.; Lee, F.E. Association of antieosinophil therapy with decreased body mass index in patients with severe asthma: A preliminary retrospective analysis. Ann. Allergy Asthma Immunol. 2019, 122, 649–650. [Google Scholar] [CrossRef]
- Helfrich, S.; Mindt, B.C.; Fritz, J.H.; Duerr, C.U. Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation. Front. Immunol. 2019, 10, 930. [Google Scholar] [CrossRef] [PubMed]
- Everaere, L.; Yahia, S.A.; Bouté, M.; Audousset, C.; Chenivesse, C.; Tsicopoulos, A. Innate lymphoid cells at the interface between obesity and asthma. Immunology 2018, 153, 21–30. [Google Scholar] [CrossRef] [PubMed]
- Matsuyama, T.; Machida, K.; Mizuno, K.; Matsuyama, H.; Dotake, Y.; Shinmura, M.; Takagi, K.; Inoue, H. The Functional Role of Group 2 Innate Lymphoid Cells in Asthma. Biomolecules 2023, 13, 893. [Google Scholar] [CrossRef] [PubMed]
- Fallon, P.G.; Ballantyne, S.J.; Mangan, N.E.; Barlow, J.L.; Dasvarma, A.; Hewett, D.R.; McIlgorm, A.; Jolin, H.E.; McKenzie, A.N. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 2006, 203, 1105–1116. [Google Scholar] [CrossRef] [PubMed]
- Duchesne, M.; Okoye, I.; Lacy, P. Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response. Front. Immunol. 2022, 13, 975914. [Google Scholar] [CrossRef] [PubMed]
- Smith, S.G.; Chen, R.; Kjarsgaard, M.; Huang, C.; Oliveria, J.-P.; O’Byrne, P.M.; Gauvreau, G.M.; Boulet, L.-P.; Lemiere, C.; Martin, J.; et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J. Allergy Clin. Immunol. 2016, 137, 75–86.e8. [Google Scholar] [CrossRef] [PubMed]
- Liu, T.; Wu, J.; Zhao, J.; Wang, J.; Zhang, Y.; Liu, L.; Cao, L.; Liu, Y.; Dong, L. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma. Respir. Med. 2015, 109, 1391–1396. [Google Scholar] [CrossRef]
- Christianson, C.A.; Goplen, N.P.; Zafar, I.; Irvin, C.; Good, J.T., Jr.; Rollins, D.R.; Gorentla, B.; Liu, W.; Gorska, M.M.; Chu, H.; et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J. Allergy Clin. Immunol. 2015, 136, 59–68.e14. [Google Scholar] [CrossRef]
- Brestoff, J.R.; Kim, B.S.; Saenz, S.A.; Stine, R.R.; Monticelli, L.A.; Sonnenberg, G.F.; Thome, J.J.; Farber, D.L.; Lutfy, K.; Seale, P.; et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015, 519, 242–246. [Google Scholar] [CrossRef]
- Björkander, S.; Maier, P.; Kere, M.; Merid, S.K.; Wirth, L.; Wiegel, W.; Ekström, S.; Kull, I.; Bergström, A.; Melén, E.; et al. Innate lymphoid cells type 2 and CD8+ T cells are perturbed in overweight and obese individuals with asthma. Allergy 2023, 78, 2533–2536. [Google Scholar] [CrossRef]
- van der Ploeg, E.K.; Golebski, K.; van Nimwegen, M.; Fergusson, J.R.; Heesters, B.A.; Martinez-Gonzalez, I.; Kradolfer, C.M.; van Tol, S.; Scicluna, B.P.; de Bruijn, M.J.; et al. Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases. Sci. Immunol. 2021, 6, eabd3489. [Google Scholar] [CrossRef] [PubMed]
- Kyriakopoulos, C.; Gogali, A.; Markozannes, G.; Kostikas, K. Biologic agents licensed for severe asthma: A systematic review and meta-analysis of randomised controlled trials. Eur. Respir. Rev. 2024, 33, 230238. [Google Scholar] [CrossRef] [PubMed]
- Porsbjerg, C.M.; Sverrild, A.; Lloyd, C.M.; Menzies-Gow, A.N.; Bel, E.H. Anti-alarmins in asthma: Targeting the airway epithelium with next-generation biologics. Eur. Respir. J. 2020, 56, 2000260. [Google Scholar] [CrossRef] [PubMed]
- Chan, R.; Stewart, K.; Misirovs, R.; Lipworth, B.J. Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma. J. Allergy Clin. Immunol. Pract. 2022, 10, 1497–1505. [Google Scholar] [CrossRef] [PubMed]
- Whetstone, C.E.; Ranjbar, M.; Omer, H.; Cusack, R.P.; Gauvreau, G.M. The Role of Airway Epithelial Cell Alarmins in Asthma. Cells 2022, 11, 1105. [Google Scholar] [CrossRef] [PubMed]
- Pelaia, C.; Pelaia, G.; Longhini, F.; Crimi, C.; Calabrese, C.; Gallelli, L.; Sciacqua, A.; Vatrella, A. Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma. Biomedicines 2021, 9, 1108. [Google Scholar] [CrossRef]
- Menzies-Gow, A.; Corren, J.; Bourdin, A.; Chupp, G.; Israel, E.; Wechsler, M.E.; Brightling, C.E.; Griffiths, J.M.; Hellqvist, Å.; Bowen, K.; et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N. Engl. J. Med. 2021, 384, 1800–1809. [Google Scholar] [CrossRef]
- Wechsler, M.E.; Ruddy, M.K.; Pavord, I.D.; Israel, E.; Rabe, K.F.; Ford, L.B.; Maspero, J.F.; Abdulai, R.M.; Hu, C.-C.; Martincova, R.; et al. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. N. Engl. J. Med. 2021, 385, 1656–1668. [Google Scholar] [CrossRef]
- Kelsen, S.G.; Agache, I.O.; Soong, W.; Israel, E.; Chupp, G.L.; Cheung, D.S.; Theess, W.; Yang, X.; Staton, T.L.; Choy, D.F.; et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J. Allergy Clin. Immunol. 2021, 148, 790–798. [Google Scholar] [CrossRef]
- Su, J.; Pitre, T.; Desai, K.; Mah, J.; Nair, P.; Ho, T.; Zeraatkar, D. Anti-epithelial-derived cytokines for severe asthma: Systematic review and meta-analysis. J. Allergy Clin. Immunol. 2023, 151, 1566–1576. [Google Scholar] [CrossRef]
- Tang, H.; Liu, N.; Feng, X.; Yang, Y.; Fang, Y.; Zhuang, S.; Dai, Y.; Liu, M.; Tang, L. Circulating levels of IL-33 are elevated by obesity and positively correlated with metabolic disorders in Chinese adults. J. Transl. Med. 2021, 19, 52. [Google Scholar] [CrossRef] [PubMed]
- Glück, J.; Glück, M.; Rogala, B.; Piecuch, J. Epithelial-Cell-Derived Cytokines in Patients with Obesity before and after Bariatric Surgery. Int. Arch. Allergy Immunol. 2022, 183, 566–571. [Google Scholar] [CrossRef] [PubMed]
- Pereira, M.J.; Azim, A.; Hetty, S.; Jui, B.N.; Kullberg, J.; Lundqvist, M.H.; Eriksson, J.W. Interleukin-33 inhibits glucose uptake in human adipocytes and its expression in adipose tissue is elevated in insulin resistance and type 2 diabetes. Cytokine 2023, 161, 156080. [Google Scholar] [CrossRef]
- Lipworth, B.; Kuo, C.R.; Chan, R. 2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management. J. Allergy Clin. Immunol. 2020, 146, 1281–1282. [Google Scholar] [CrossRef] [PubMed]
- Schneider, A.; Brunn, B.; Hapfelmeier, A.; Schultz, K.; Kellerer, C.; Jörres, R.A. Diagnostic accuracy of FeNO in asthma and predictive value for inhaled corticosteroid responsiveness: A prospective, multicentre study. eClinicalMedicine 2022, 50, 101533. [Google Scholar] [CrossRef]
- Erkoçoğlu, M.; Kaya, A.; Özcan, C.; Akan, A.; Vezir, E.; Azkur, D.; Kara, Ö.; Demirel, F.; Ginis, T.; Civelek, E.; et al. The effect of obesity on the level of fractional exhaled nitric oxide in children with asthma. Int. Arch. Allergy Immunol. 2013, 162, 156–162. [Google Scholar] [CrossRef] [PubMed]
- Barański, K.; Kocot, K. The Effect of Obesity on Fractional Exhaled Nitric Oxide in School-Aged Children. Children 2022, 9, 1406. [Google Scholar] [CrossRef]
- Al Khathlan, N.; Salem, A.M. The Effect of Adiposity Markers on Fractional Exhaled Nitric Oxide (FeNO) and Pulmonary Function Measurements. Int. J. Gen. Med. 2020, 13, 955–962. [Google Scholar] [CrossRef] [PubMed]
- Flashner, B.M.; Rifas-Shiman, S.L.; Oken, E.; Camargo, C.A.; Platts-Mills, T.J.; Workman, L.; Litonjua, A.A.; Gold, D.R.; Rice, M.B. Obesity, sedentary lifestyle, and exhaled nitric oxide in an early adolescent cohort. Pediatr. Pulmonol. 2020, 55, 503–509. [Google Scholar] [CrossRef]
- Deng, K.; Zhang, X.; Liu, Y.; Cheng, G.P.; Zhang, H.P.; Wang, T.; Wang, L.; Li, W.M.; Wang, G.; Wood, L. Visceral obesity is associated with clinical and inflammatory features of asthma: A prospective cohort study. Allergy Asthma Proc. 2020, 41, 348–356. [Google Scholar] [CrossRef]
- Giovannelli, J.; Chérot-Kornobis, N.; Hulo, S.; Ciuchete, A.; Clément, G.; Amouyel, P.; Matran, R.; Dauchet, L. Both exhaled nitric oxide and blood eosinophil count were associated with mild allergic asthma only in non-smokers. Clin. Exp. Allergy 2016, 46, 543–554. [Google Scholar] [CrossRef]
- Freitas, P.D.; Ferreira, P.G.; Silva, A.G.; Stelmach, R.; Carvalho-Pinto, R.M.; Fernandes, F.L.A.; Mancini, M.C.; Sato, M.N.; Martins, M.A.; Carvalho, C.R.F. The Role of Exercise in a Weight-Loss Program on Clinical Control in Obese Adults with Asthma. A Randomized Controlled Trial. Am. J. Respir. Crit. Care Med. 2017, 195, 32–42. [Google Scholar] [CrossRef]
- Tam, A.; Wadsworth, S.; Dorscheid, D.; Man, S.P.; Sin, D.D. The airway epithelium: More than just a structural barrier. Ther. Adv. Respir. Dis. 2011, 5, 255–273. [Google Scholar] [CrossRef] [PubMed]
- Singh, S.; Dutta, J.; Ray, A.; Karmakar, A.; Mabalirajan, U. Airway Epithelium: A Neglected but Crucial Cell Type in Asthma Pathobiology. Diagnostics 2023, 13, 808. [Google Scholar] [CrossRef] [PubMed]
- Raby, K.L.; Michaeloudes, C.; Tonkin, J.; Chung, K.F.; Bhavsar, P.K. Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD. Front. Immunol. 2023, 14, 1201658. [Google Scholar] [CrossRef] [PubMed]
- Heijink, I.H.; Kuchibhotla, V.N.S.; Roffel, M.P.; Maes, T.; Knight, D.A.; Sayers, I.; Nawijn, M.C. Epithelial cell dysfunction, a major driver of asthma development. Allergy 2020, 75, 1902–1917. [Google Scholar] [CrossRef] [PubMed]
- Ordoñez, C.L.; Khashayar, R.; Wong, H.H.; Ferrando, R.; Wu, R.; Hyde, D.M.; Hotchkiss, J.A.; Zhang, Y.; Novikov, A.; Dolganov, G.; et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit. Care Med. 2001, 163, 517–523. [Google Scholar] [CrossRef] [PubMed]
- Fahy, J.V. Goblet cell and mucin gene abnormalities in asthma. Chest 2002, 122 (Suppl. 6), 320S–326S. [Google Scholar] [CrossRef] [PubMed]
- Thomas, B.; Rutman, A.; Hirst, R.A.; Haldar, P.; Wardlaw, A.J.; Bankart, J.; Brightling, C.E.; O’Callaghan, C. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J. Allergy Clin. Immunol. 2010, 126, 722–729.e2. [Google Scholar] [CrossRef]
- Lambrecht, B.N.; Hammad, H. Death at the airway epithelium in asthma. Cell Res. 2013, 23, 588–589. [Google Scholar] [CrossRef]
- Listyoko, A.S.; Okazaki, R.; Harada, T.; Inui, G.; Yamasaki, A. Impact of obesity on airway remodeling in asthma: Pathophysiological insights and clinical implications. Front. Allergy 2024, 5, 1365801. [Google Scholar] [CrossRef]
- Kim, H.R.; Ingram, J.L.; Que, L.G. Effects of Oxidative Stress on Airway Epithelium Permeability in Asthma and Potential Implications for Patients with Comorbid Obesity. J. Asthma Allergy 2023, 16, 481–499. [Google Scholar] [CrossRef] [PubMed]
- Winnica, D.E.; Monzon, A.; Ye, S.; Vladar, E.K.; Saal, M.; Cooney, R.; Liu, C.; Sharma, S.; Holguin, F. Airway epithelial Paraoxonase-2 in obese asthma. PLoS ONE 2022, 17, e0261504. [Google Scholar] [CrossRef] [PubMed]
- Salvator, H.; Grassin-Delyle, S.; Naline, E.; Brollo, M.; Fournier, C.; Couderc, L.-J.; Devillier, P. Contrasting Effects of Adipokines on the Cytokine Production by Primary Human Bronchial Epithelial Cells: Inhibitory Effects of Adiponectin. Front. Pharmacol. 2020, 11, 56. [Google Scholar] [CrossRef]
- Peña-García, P.E.; Fastiggi, V.A.; Mank, M.M.; Ather, J.L.; Garrow, O.J.; Anathy, V.; Dixon, A.E.; Poynter, M.E. Bariatric surgery decreases the capacity of plasma from obese asthmatic subjects to augment airway epithelial cell proinflammatory cytokine production. Am. J. Physiol. Lung Cell. Mol. Physiol. 2024, 326, L71–L82. [Google Scholar] [CrossRef] [PubMed]
- Xu, Z.; Forno, E.; Acosta-Pérez, E.; Han, Y.; Rosser, F.; Manni, M.L.; Canino, G.; Chen, W.; Celedón, J.C. Differential gene expression in nasal airway epithelium from overweight or obese youth with asthma. Pediatr. Allergy Immunol. 2022, 33, e13776. [Google Scholar] [CrossRef]
- Hasegawa, K.; Tsugawa, Y.; Chang, Y.; Camargo, C.A. Risk of an asthma exacerbation after bariatric surgery in adults. J. Allergy Clin. Immunol. 2015, 136, 288–294.e8. [Google Scholar] [CrossRef] [PubMed]
- Wu, A.Y.; Peebles, R.S. The GLP-1 receptor in airway inflammation in asthma: A promising novel target? Expert Rev. Clin. Immunol. 2021, 17, 1053–1057. [Google Scholar] [CrossRef]
- Kaplan, A.G.; Kim, J.W. Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: A Review of the Current Evidence. Pulm. Ther. 2022, 8, 343–358. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Imayama, I.; Eccles, J.D.; Ascoli, C.; Kudlaty, E.; Park, G.Y. Body Weight and Allergic Asthma: A Narrative Review. J. Clin. Med. 2024, 13, 4801. https://doi.org/10.3390/jcm13164801
Imayama I, Eccles JD, Ascoli C, Kudlaty E, Park GY. Body Weight and Allergic Asthma: A Narrative Review. Journal of Clinical Medicine. 2024; 13(16):4801. https://doi.org/10.3390/jcm13164801
Chicago/Turabian StyleImayama, Ikuyo, Jacob D. Eccles, Christian Ascoli, Elizabeth Kudlaty, and Gye Young Park. 2024. "Body Weight and Allergic Asthma: A Narrative Review" Journal of Clinical Medicine 13, no. 16: 4801. https://doi.org/10.3390/jcm13164801